Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q4 2024 (December 31)8holders
2new positions
1sold out
$1.11avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, unchanged from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Graypoint LLC ($910K), Vestcor Inc ($89K) and B & T Capital Management DBA Alpha Capital Management ($24K).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q4 2024)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $910K |
| Exits | 1 | $14K |
All 13F filers, Q3 2024 → Q4 2024: 827,690 shares bought and 24,810 shares sold, net +802,880 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Graypoint LLC | — | New | 827,590 | $910K |
| Vestcor Inc | — | No change | 70,832 | $89K |
| B & T Capital Management DBA Alpha Capital Management | — | No change | 22,222 | $24K |
| HRT Financial LP | — | Reduce -24.8% | 21,253 | $23K |
| Foster Victor Wealth Advisors, LLC | — | Reduce -17.3% | 18,328 | $22K |
| Wolverine Asset Management LLC | — | Reduce -5.8% | 13,900 | $15K |
| Clear Street LLC | — | New | 100 | $110 |
| Tower Research Capital LLC (TRC) | — | No change | 42 | $46 |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.